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Abstract
Objective: this study aimed to determine the incidence of nos-
ocomial infections, the risk factors and the impact of these infec-
tions on mortality among patients undergoing to cardiac surgery. 
Methods: Retrospective cohort study of 2060 consecutive 
patients from 2006 to 2012 at the Santa Casa de Misericórdia 
de Marília. 
Results: 351 nosocomial infections were diagnosed (17%), 
227 non-surgical infections and 124 surgical wound infec-
tions. Major infections were mediastinitis (2.0%), urinary 
tract infection (2.8%), pneumonia (2.3%), and bloodstream 
infection (1.7%). The in-hospital mortality was 6.4%. Inde-
pendent variables associated with non-surgical infections 
were age ≥ 60 years (OR 1.59, 95% CI 1.09 to 2.31), ICU 
stay ≥ 2 days (OR 5, 49, 95% CI 2.98 to 10, 09), mechanical 
ventilation ≥ 2 days (OR11, 93, 95% CI 6.1 to 23.08), use 
of urinary catheter ≥ 3 days (OR 4.85 95% CI 2.95 -7.99). 
Non-surgical nosocomial infections were more frequent in 
patients with surgical wound infection (32.3% versus 7.2%, 
OR 6.1, 95% CI 4.03 to 9.24). Independent variables associ-
ated with mortality were age greater than 60 years (OR 2.0; 
95% CI 1.4 to3.0), use of vasoactive drugs (OR 3.4, 95% CI 
1.9 to 6, 0), insulin use (OR 1.8; 95% CI 1.2 to 2.8), surgical 
reintervention (OR 4.4; 95% CI 2.1 to 9.0) pneumonia (OR 
4.3; 95% CI 2.1 to 8.9) and bloodstream infection (OR = 4.7, 
95% CI 2.0 to 11.2). 
Conclusion: Non-surgical hospital infections are common in 
patients undergoing cardiac surgery; they increase the chance 
of surgical wound infection and mortality.
Descriptors: Cross Infection. Risk Factors. Mortality. Tho-
racic Surgery. Surgical Wound Infection.
Resumo
Objetivo: O objetivo deste estudo foi determinar as taxas das 
infecções hospitalares, os fatores de risco associados e o impac-
to destas infecções na mortalidade dos pacientes submetidos à 
cirurgia cardíaca.
Métodos: coorte retrospectivo que incluiu 2060 pacientes 
consecutivos, no período de 2006 a 2012 na Santa Casa de Mise-
ricórdia de Marília. 
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case-control, using data from the Hospital Infections Control 
Service (HICS). The HICS performs active surveillance of HI, 
tracking daily all surgical patients, using a standardized form 
of data collection. The HICS participates in the diagnostic and 
therapeutic discussion of HI cases with the medical team. The 
diagnostic criteria of HI used were those recommended by the 
Center for Diseases Control and Prevention (CDC)[7].
All patients who underwent cardiac surgery during 2006-
2012 had their data assessed since their admission until dis-
charge or death. Despite not having been performed system-
atically surveillance after discharge of HI by the HICS, all 
patients were followed-up postoperatively during the outpa-
tient care by the surgical team. The cases requiring hospital 
readmission, guidance on the use of antibiotics, dressings or 
with positive cultures were assessed by the HICS.
Therefore, we defined as cases the patients diagnosed 
with postoperative wound infection of the sternal region and 
compared with those without this diagnosis (control); in the 
same way, patients who survived (control) were compared 
to those who died (case) during hospital stay, in order to de-
termine the variables associated with these outcomes. Risk 
factors for SSI on the site of removal of the graft were not as-
sessed. The scores of the European System for Risk Assess-
ment in Cardiac Surgery (EuroSCORE) were not calculated 
because not all variables were systematically recorded in the 
early years of the study.
This study was performed at the Santa Casa de Misericor-
dia de Marilia, which is a philanthropic tertiary hospital with 
200 beds and regional reference of SUS (Unified Health Sys-
tem) for cardiac surgery. It has a cardiac ICU and a general 
ICU with eight beds each.
INTRODUCTION
 
The hospital infections (HI) represent one of the most 
common complications in hospitalized patients undergoing 
surgical procedures. IH rates vary from 5% to 20% and are 
associated with increased morbidity, mortality, length of hos-
pital stay and hospital costs[1,2].
Patients undergoing cardiac surgery are particularly sus-
ceptible to these infections, and surgical site infections (SSI) 
are the most studied due to the most serious consequences 
associated both to patients and hospital. These patients also 
have several risk factors for nonsurgical HI, such admission 
to ICU (intensive care unit), use over variable time of inva-
sive devices such as central venous catheter (CVC), urinary 
catheter (UC) and mechanical ventilation (MV)[3,4].
Published data suggest that rates of HI postoperative-
ly in these patients may vary from 3.5% to 21%, the most 
frequent being the ventilator-associated pneumonia (VAP), 
catheter-associated urinary tract infections (CAUTI), prima-
ry bloodstream infection (PBSI) or CVC infection[5,6].
The overall mortality of these patients developing HI can 
reach 25%[1-3]. However, there are few studies in Brazil that 
assessed the impact of non-surgical infections in outcomes of 
these patients. Thus, the aim of this study was to determine 
the rate of HI (surgical and nonsurgical) among patients un-
dergoing cardiac surgery, the risk factors and the impact of 
these infections on patient outcomes.
METHODS
We performed a retrospective cohort study with nested 
Abbreviations, acronyms & symbols
BMI Body mass index
CABG Coronary artery bypass grafting
COPD Chronic obstructive pulmonary disease
CVC Central venous catheter
DM Diabetes mellitus
HI Hospital infection
HICS Hospital infection control service
ICU Intensive care unit
MV Mechanical ventilation
PBSI Primary bloodstream infection
SSI Surgical site infection
UC Urinary catheter
UTI Urinary tract infection
VAP Ventilator-associated pneumonia
Resultados: Foram diagnosticadas 351 infecções hospitala-
res (17%), sendo 227 infecções não cirúrgicas e 124 infecções 
cirúrgicas. As principais infecções foram: mediastinite (2,0%), 
infecção urinária (2,8%), pneumonia (2,3%), infecção da cor-
rente sanguínea (1,7%). A mortalidade global intra-hospitalar 
foi de 6,4%. As variáveis independentes associadas às infecções 
não cirúrgicas foram: idade ≥ 60 anos (OR 1,59; IC95%1,09-
2,31), internação em UTI ≥ 2 dias (OR5,49; IC95% 2,98-10,09), 
ventilação mecânica ≥ 2 dias (OR11,93; IC95% 6,1 - 23,08), uso 
de sonda vesical ≥3 dias (OR 4,85 IC95% 2,95 -7,99). Infecções 
hospitalares não cirúrgicas foram mais frequentes em pacien-
tes com infecção cirúrgica (32,3% versus 7,2%; OR 6,1; IC95% 
4,03- 9,24). As variáveis independentes associadas a mortalida-
de foram: idade ≥60 anos (OR= 2,0 ; IC 95% 1,4-3,0), uso de 
droga vasopressora (OR 3,4; IC95% 1,9-6,0), uso de insulina 
(OR=1,8; IC 95% 1,2-2,8), reintervenção cirúrgica (OR=4,4 
IC95% 2,1-9,0) pneumonia (OR=4,3 IC95% 2,1-8,9) e infecção 
da corrente sanguíneas (OR=4,7; IC95% 2,0-11,2).
Conclusão: infecções hospitalares não cirúrgicas são fre-
quentes pós cirurgia cardíaca, e aumentam a chance de infecção 
cirúrgica e a mortalidade.
Descritores: Infecção Hospitalar. Procedimentos Cirúrgicos 
Cardíacos. Fatores de Risco. Mortalidade. Infecção da Ferida 
Operatória.
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A descriptive analysis of the data by calculating the mean 
and standard deviation for continuous variables and propor-
tions of categorical variables was performed. The Pearson 
chi-square test was used to compare proportions, the Student 
t test was used to compare means. The P value of<0.05 was 
considered statistically significant. Possible risk factors sta-
tistically significant in univariate analysis were included in 
multiple logistic regression analysis by forward conditional 
technique to identify the variables associated with the occur-
rence of HI and death. The calibration of the model (good-
ness of fit) was estimated using the Hosmer Lemeshow test 
(HL) (high values of P means that the model is fit to the data). 
We used the SPSS (Statistical Package for Social Science) 
version 18.0 for Windows (SPSS INC., Chicago, IL) for data 
analysis. This study was approved by the Research Ethics 
Committee under number 094/10.
RESULTS
In the period from 2006 to 2012, 2060 surgeries were 
performed. Coronary artery bypass grafting (CABG) was 
performed in 1375 (66.8%) patients, valve surgery in 466 
(22.6%) and other cardiac surgeries (which included aneu-
rysm, congenital heart disease, aortic coarctation, Bentall 
De Bono) were performed in 219 (10.6%) patients. The 
grafts more used were internal thoracic artery and saphe-
nous vein in 767 (37.2%) patients, in 304 (14.8%) patients 
were performed more than one procedure in the same sur-
gery. Surgical revision for bleeding was performed in 60 
(2.9%) patients.
In this population, males predominated (63%), the av-
erage age was 58 +14.5 years. Presence of risk factors and 
or cardiovascular disease were identified in 1475 (71.6%) 
patients, highlighting prior acute myocardial infarction 
(15.6%), hypertension (63.8%), dyslipidemia (32%), diabe-
tes mellitus (23.5%), smoking (19.7%).
Antibiotic prophylaxis was performed in 96.7% (n=1983) 
of procedures, regardless performing saphenous vein graft-
ing for obtaining the graft. First-generation cephalosporin 
was used in 98 % (1944 ) of cases. From 2010 an aminogly-
coside was added to the prophylactic regimen of 23% (449) 
of patients who had > 4 days of preoperative hospital stay; 
in 2012, of 254 patients who underwent heart surgery in this 
year, 12.2% (n=31) received vancomycin associated with 
aminoglycoside in prophylactic regimen.
The average hospital stay was 13.36+12.4 days and 
in-hospital overall mortality was 6.4% (n=132). Table 1 
shows the general characteristics of the patients and the pre-
operative and postoperative periods. 351 HI were diagnosed 
in 265 (12.9%) patients, corresponding to an incidence of 
17% and 124 SSI (35.3%) and 227 (64.7%) infections in 
other topographies. Forty patients with SSI (32.3%) also had 
infection in other topography. The most frequent HI and their 
rates are described in Table 2.
Table 1. Characteristics of patients and procedures performed.
No. of Patients
Age > =60 years






Preoperative hospitalization in days ± SD
Mean surgical time in minutes± SD
Time of cardiopulmonary bypass in minutes+ SD
Insulin use in the postoperative
Vasoactive drug use of postoperative 
Patients using CVC in the postoperative
Average time in days of UC use ±SD 
Patients using UC in the postoperative
Average time in days of CVD + SD
Patients under MV in the postoperative 
Average time in days under MV ± SD
Average ICU days ± SD








































CVC: central venous catheter; MV: mechanical ventilation; UC: urinary catheter; ICU: intensive care unit, SD: 
standard deviation
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The overall rate of SSI was 6.0% (n=124), varying with 
the type of surgery, 7.0% in CABG surgeries (n=96), 4.9% 
(n=23) in the valve surgeries and 2.3% (n=5) in the other 
surgeries. Complication occurred in 2.0% (n=41) patients. 
Infection at the saphenous occurred in 2.2% (19/ 856) of pa-
tients who had saphenous resection for obtaining graft.
The etiologic agent was identified in 69 (55.6%) cas-
es with SSI and the gram negative bacteria were the most 
frequently isolated, highlighting the Klebsiella pneumoni-
ae (26.0%), and Pseudomonas aeruginosa (13.0%). Twen-
ty-eight percent (n=5) were of Klebsiella pneumoniae 
producing extended spectrum beta-lactamases (ESBL). Kleb-
siella pneumoniae producing carbapenemase (KPC) were 
not identified. Sensitivity to gentamicin, amikacin, cefepime, 
imipenem was 77.7%, 83.3%, 72.2% and 94.4% among iso-
lates of Klebsiella pneumoniae and 77.7%, 88.8%, 100% and 
100% among isolates of Pseudomonas aeruginosa.
Staphylococcus aureus was isolated in 21% (n=15) of 
cases, 33% (n=5) were resistant to oxacillin. The etiologic 
agents identified were not related to baseline patient charac-
teristics or surgical procedure.
Tables 3, 4 and 5 describe the results of the univariate 
analysis for the occurrence of SSI in the sternum, non-surgi-
cal HI and evolution to death. Tables 6, 7 and 8 describe the 
results of logistic regression analysis for the occurrence of 
SSI, nonsurgical HI and death.
Table 2. Main hospital infections.
Total of hospital infection
Total of patients with hospital infection
Surgical site infection
Urinary tract infection









































Use of urinary catheter ≥ 3days
<3 days
Use of vascular catheter ≥ 3days
<3 days
Respirator ≥ 2 days
< 2 days
Mean ICU stay  in days ± SD
Mean hospital stay in days + SD
Death
Survival
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Table 4. Variables associated with the occurrence of surgical site infection (SSI).
No. patients
Age < 60 years
> = 60 years
Body mass index ≥ 30kg/m2
< 30  Kg/m2
Preoperative hospitalization 
in days± SD
Mean surgical time in minutes ±SD




Postoperative insulin use 
Yes
No  






Ventilation associated pneumonia 
Yes
No






Mean of ICU stay in days ± SD
Mean of hospital stay in days ± SD
Death
Survival
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Table 6. Variables associated with the occurrence of non-surgical infection in logistic regression analysis.
Age > = 60 years
ICU stay > 2days
Use of urinary catheter ≥ 3days
Mechanical ventilation ≥ 2days
Constant 

















Table 5. Variables associated with evolution in the univariate analysis.
Age <60 years
= >60
Body mass index> = 30Kg/m2
< 30Kg/m2
Mean of preoperative hospital stay in days± SD




Postoperative use of insulin 
Yes
No
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DISCUSSION
Patients undergoing cardiac surgery are more likely to de-
velop HI because several risk factors for coronary heart disease 
are also considered at risk for the development of HI, including 
advanced age, diabetes mellitus, obesity and smoking. In ad-
dition, these patients remained in the ICU for a variable time, 
where they are subjected to multiple invasive procedures[1-6,8,9].
This study assessed the occurrence of HI, including 2060 
patients from a single center undergoing cardiac surgery, and 
noted an overall rate of 17.0% of HI, while 64.7% of these in-
fections were HI unrelated to the surgical site, highlighting UTI 
(2.8%), VAP (2.5%), Primary Blodstream Infection (PBSI) 
(1.7%) and infection of the site of insertion of the CVC (0.8%).
The overall in-hospital mortality observed was 6.4%, be-
ing higher in patients ≥ 60 years, who required reoperation 
for bleeding, which used vasoactive drugs postoperatively, 
and had VAP or PBSI.
HI rates reported in patients undergoing cardiac surgery 
are variable. In the study by Bouza et al.[5], involving 42 hos-
pitals in 13 European countries, the prevalence of HI was 
26.8%. Other studies including one center reported overall 
rates of HI 3.5% to 21%[3, 8,9]. These variations are probably 
related to differences in the population studied, the charac-
teristics of the hospital and the care process, as well as the 
type of epidemiological surveillance adopted and the degree 
of compliance to control measures advocated.
In general, it is recommended surveillance of SSI after 
discharge, since they may appear within 30 days after sur-
gery, with reported median time from surgery until diagnosis 
of sternal SSI of 15 days[10,11]. In study by Berg et al.[11], in 
Norway, where the average hospital stay was 6 days, most of 
the SSI on the sternal wound was diagnosed after discharge. 
In our study, however, as the average length of stay was very 
high (13.3+12.3 days) and the surgical team performed sys-
tematically assessment of patients postoperatively; therefore 
we believe that losses in cases with sternal SSI, if it occurred, 
were small and limited to superficial infections. Regarding 
the non-surgical infection, the surveillance only during hos-
pital stay has been considered appropriate.
In this study, the non-surgical HI were more frequent among 
older patients and those who stayed longer in the ICU, as it is 
known as the hospital sector with the highest rates of HI, as re-
ported by other authors[1,12]. Likewise, the use and length of stay 
of UC, MV and CVC were associated with the occurrence of 
nonsurgical HI, in logistic regression analysis. These are the fac-
tors most frequently reported in several studies[3,4,6,8,9]. Invasive 
devices break down the natural barrier of defense and can be a 
gateway to microorganisms during its insertion or manipulation. 
It is estimated that 50% to 70% of these infections could be pre-
vented if strategies considered effective were implemented and 
systematically incorporated into the daily care of these patients, 
for example, the early removal of invasive devices[2].
In the medical literature, it has been described mediastinitis 
occurrence from 0.4% to 5% of the patients. In our study, the 
observed overall rate of SSI was 6.4% and the rate of mediasti-
nitis was 2.0%, similar to values reported by Brazilian authors, 
who reported rates of mediastinitis from 1.3% to 5.6%[13-15]. 
Table 7. Variables associated with the occurrence of surgical site infection in logistic regression analysis.
Postoperative use of vasoactive drugs





























Table 8. Variables associated with evolution in the logistic regression analysis.
Age≥60 years
Postoperative use of vasoactive drugs
Postoperative use of insulin
Pneumonia
Primary infection of the bloodstream
Surgical reintervention
Constant
























Rev Bras Cir Cardiovasc | Braz J Cardiovasc Surg
Rev Bras Cir Cardiovasc 2014;29(2):167-76Conterno LO, et al. - Impact of hospital infections on patients outcomes 
undergoing cardiac surgery at Santa Casa de Misericórdia de Marília
The rate of infection at the site of the graft removal (2.2%) 
is among those described by other authors[10,11], however, this 
study did not assess the factors associated with its occurrence.
In this study, the risk factors associated with the occur-
rence of SSI of sternal wound, in the logistic regression anal-
ysis were: surgical reintervention, use of vasoactive drugs 
and insulin postoperatively, VAP diagnosis and PBSI.
Surgical reintervention is considered an important risk 
factor for SSI, probably due to greater surgical manipulation 
and delayed sternal closure. In the present study, this event 
has increased by six times the chance of SSI and four times 
the chance of dying as described by other authors[15-18].
Hemodynamic instability or postoperative shock have been 
identified as associated with the development of mediastinitis and 
nonsurgical HI[3,8]. The use of vasoactive drugs postoperatively 
was interpreted as a marker of hemodynamic instability, which 
increased the chance of SSI 2.9 times (OR 2.9 95% CI 1,5 to 4,1).
Despite DM being one of the risk factors most often asso-
ciated with the SSI, in this study this was not observed. There 
was association between insulin use and the occurrence of post-
operative SSI, however, insulin may have been necessary due 
to previously undiagnosed DM or by hyperglycemia secondary 
to surgical stress, usually seen in major surgery[19]. Thus, this 
finding should be interpreted with caution, because confounding 
variables not adequately controlled may explain this result.
It is known that infections at other sites increase the risk 
for SSI because they can represent the gateway to the micro-
organisms colonize the wound, or transmission by contact or 
blood[6]. In our study, patients with SSI had also more UTI, 
VAP, CVC infection, PBSI, when compared with those with-
out SSI. Although it was not possible in all cases clearly es-
tablish what is the temporal relationship of these infections, 
they can be interpreted as adverse events arising from the co-
existence of multiple risk factors present in this population.
In the study by Le Guillou et al.[6] 5% to 15% of SSI in 
cardiac surgery were assigned to CVC-related infections, 
both when the same agent was isolated in both topographies 
or not. PBSI has been described as one of the most frequent 
HI in this population of patients with major impact on the 
evolution, because some of the risk factors reported for this 
infection overlap factors associated with SSI, such as age, 
COPD, duration of mechanical ventilation[4,5,20].
As noted by other authors[9,16], the duration of hospitaliza-
tion was higher among patients with SSI compared with those 
without SSI, as well as among patients with nonsurgical HI 
compared with those without infection. One cannot say if the 
prolonged staying was cause or consequence of SSI or oth-
er infections, but it can certainly be considered a marker of 
increased morbidity and increased costs associated with care, 
one of the main consequences of HI for the health system.
At Santa Casa de Marilia has been more frequent isolation 
of gram negative bacteria (Klebsiella pneumoniae and Pseudo-
monas aeruginosa), more than Staphylococcus aureus, in cul-
tures of surgical specimens. One possible explanation may be 
advanced age, prolonged hospital stay during preoperative pe-
riod, diabetes mellitus, which were prevalent in this population, 
and are considered risk factors for SSI for gram negative[21]. This 
prompted a review of the scheme of an antibiotic prophylax-
is for patients with prolonged preoperative hospital stay. From 
2010, aminoglycoside was associated to cefazolin in 23% of 
cases, in order to expand coverage for gram negative bacteria 
in patients with preoperative hospitalization > 4 days. There is 
little evidence to support the use of aminoglycoside as a prophy-
lactic drug in cardiac surgery, in addition to exist a concern with 
adverse events related to the use of this group of antimicrobials. 
However, gentamicin associated with other antibiotics with an-
ti-staphylococcal action has been adopted in some hospitals in 
England, due to high rates of Clostridium difficile infection and 
its association with the use of cephalosporins, which are now 
little used. The study by Insker[22] that assessed antibiotic pro-
phylaxis use in 23 English cardiac centers found that 61% of 
these used gentamicin associated with flucloxacillin.
Vancomycin was not the standard antibiotic prophylaxis 
of the Santa Casa de Marília during the study period, since 
most of the S. aureus isolates from surgical patients were 
sensitive to oxacillin. However, in 2012 vancomycin already 
was part of the prophylactic scheme of 12.2% of patients 
with prolonged preoperative hospitalization, in order to also 
try to ensure better coverage for oxacillin-resistant Staphylo-
coccus aureus. Due to the changes that may be occurring in 
bacteria isolated from the SSI and the sensitivity pattern, we 
believe it is imperative to continue monitoring the rates of 
SSI and the etiologic agents involved in order to assess the 
impact and appropriateness of prophylactic standard and the 
used for specific patient groups in this institution.
The global in-hospital mortality was 6.4% and statistically 
different between patients with and without SSI (17 % versus 
4.8%, OR), VAP (25% versus 5.9%), tracheobronchitis (15.4% 
versus 6.2%), PBSI (31.4% versus 6.0%). In the literature, the 
mortality reported in patients undergoing cardiac surgery who 
develop HI varies from 4% for UTI[3] to 35% for VAP[4]. Mortality 
among patients with mediastinitis was 24.4% and 6.0% among 
patients without this complication. Mediastinitis increased by 
five times the chance of dying (OR 5.0 95% CI 2.4 10.50). 
These rates are similar to those described by national and inter-
national authors, who reported a mortality rate between 14% to 
42%[13,14,17]. There was no statistically significant difference in 
mortality when the infection was superficial or deep.
The logistic regression analysis identified independent 
association between mortality and the following variables: 
age ≥ 60 years, use of vasoactive drug postoperatively, VAP, 
PBSI and surgical reintervention. However, SSI was not an 
independent variable associated with death in this series.
Kollef et al.[3] assessed the impact of SSI after cardiac sur-
gery and also identified VAP and PBSI as  independent risk 
factors for multiple organ dysfunction and mortality.
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It has long been known that age is considered an independent 
risk factor for mortality, particularly when associated with the oc-
currence of infection[12]. Rahamanian et al.[23] in a study involving 
more than 6000 patients identified the following variables associ-
ated with death in patients undergoing cardiac surgery: age > 70 
years (OR 1.4 95 CI 1.1 to 1.9), sepsis (OR 1.6 95% CI 1.0 to 2.6), 
reoperation ( OR 1.5 95% CI 1.1 to 2.1) and hemodynamic insta-
bility (OR 2.2 95% CI 1.2 to 3.9), data very similar to our study.
Pneumonia and bloodstream infection are independent risk 
factors for hospital mortality in ICU patients, with attributed 
mortality ranging from 5% to 70%[2,20]. In the study performed 
in eight European countries[4], the mortality among patients un-
dergoing cardiac surgery who developed pneumonia was 35%.
Our study has some limitations because it is an observational 
study, performed in a single hospital and the identification of HI 
after discharge have been performed in the ambulatory by the 
surgical teams, and only then assessed by HICS. Although the 
length of hospital stay was long, there is the possibility that the 
HICS has not been called to assess some patients, particularly 
those with superficial infections, not requiring hospital readmis-
sion; or cultures were not collected for their diagnosis and did 
not require antibiotic orientation. We believe that patients with 
deep infection or mediastinitis were all included. Another as-
pect to be mentioned is that, although the main objective was 
assess risk factors for nonsurgical HI and its impact on patient 
outcomes, overall mortality observed was not adjusted for the 
EuroSCORE values, because not all variables were recorded for 
its calculation in the initial years of study.
However, the results of this study confirm the risk factors 
and the negative impact of non surgical HI on outcomes of 
these patients and points to some possible improvement.
It is known that the incidence of HI among patients un-
dergoing cardiac surgery depends on factors related to the 
hospital, the patient’s characteristics, invasive procedures, 
the preventive measures that are implemented and the level 
of compliance of health professionals to these measures[24].
 In this sense, it is necessary that strategies with proven ef-
fectiveness for the prevention of surgical site and nonsurgical 
HI be planned before be actually adopted. Special attention 
should be given to the factors liable to modification related 
to the care process, and to the multiple risk factors for the oc-
currence of HI present in this population. Such measures re-
quire major behavioral changes, which should be encouraged 
by in-service education, audit and continuous feedback, since 
the benefits of its application can only be achieved when the 
membership compliance reaches 100%, a scenario still far 
from being achieved in most hospitals[2,25].
CONCLUSIONS
 
Patients who underwent cardiac surgery had increased 
chance of developing infections in various topographies, par-
ticularly UTI, VAP, PBSI and CVC infection, besides the 
SSI. The use of postoperative vasoactive drugs and surgical 
reintervention were identified as risk factors for both  sternal 
SSI or nonsurgical infections. The sternal SSI was associat-
ed with the occurrence of pneumonia, bloodstream infection 
and the use of insulin in the postoperative period. Gram-neg-
ative bacteria were the most frequently identified in these in-
fections. The age, length of ICU stay, length of stay of UC, 
CVC and MV were predictors of the development of nonsur-
gical HI.
Independent variables associated with mortality were 
age, VAP, PBSI, surgical reintervention, use of insulin and 
vasoactive drugs postoperatively.
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